Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual Trigger vs GnRH agonist Trigger for Elective Fertility Preservation
2021-002467-22Phase 4Active
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Jun 2021
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in female infertility comparing Dual trigger (rhCG + triptorelin) with GnRH agonist trigger (triptorelin alone) (2 arms). Primary endpoint: Number of mature oocytes (MII) retrieved. Started Jun 2021; status: active.
02
Drugs
recombinant human chorionic gonadotrophintriptorelin
03
Conditions
female infertility
Beyond the preview
Go deeper on 2021-002467-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002467-22.